World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. Still, the pharma industry is fighting hard to keep it off the table.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. After this period, CMS will begin to include physician-administered drugs covered under Part B in the program.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Nixon Gwilt Law

MAY 26, 2023

The following Category III CPT codes are effective as of January 1, 2023, and are set to expire January 1, 2028, unless each code is individually modified to extend its expiration date or provide permanent payment. Remote Therapeutic Monitoring (“RTM”). For information on how Nixon Gwilt helps DTx companies, click here.

Healthcare 119

Healthcare Healthcare Marketing Healthcare Provider 119

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Representative Training

JANUARY 29, 2025

While biologics only account for 2% of overall prescriptions, they contribute to 37% of net drug spending [1]. The global biosimilars market is projected to grow beyond $68 billion by 2028, as more biologic patents are set to expire and generic manufacturers are expected to enter and evolve the market with their business practices. [4]

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52